Europe Pharmaceuticals & Healthcare Q3 2018
The Europe region will continue to attract significant investment from multinational pharmaceutical firms, althoughdrugmakers will find different opportunities in the Western and Emerging Europe sub-regions due to region-specific trends. Themore developed Western markets will continue to be favoured by innovative drugmakers due to stronger regulatory oversight andgreater purchasing power, although growth in these markets will be suppressed by aggressive cost-containment. Revenue growthpotential is significant in Emerging Europe due to the expansion of healthcare access; however, the majority of growth will be drivenby generic drug sales.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook